Ongoing discussion about the US clinical Lyme trials.
Department of Psychiatry, Columbia University, New York, NY; Lyme and Tick-Borne Diseases Research Center, Columbia University Medical Center, New York, NY.
Brian A
BA
Fallon
Division of Biostatistics, New York University, New York, NY; Department of Child and Adolescent Psychiatry, New York University, New York, NY.
Eva
E
Petkova
Department of Psychiatry, Columbia University, New York, NY; Neuropsychology Laboratory, Division of Molecular Imaging and Neuropathology, New York State Psychiatric Institute, New York, NY.
John G
JG
Keilp
Department of Neurology, Columbia University, New York, NY.
Carolyn B
CB
Britton
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D025065:Borrelia burgdorferi; D002443:Ceftriaxone / Q000627:therapeutic use*; D003072:Cognition Disorders / Q000188:drug therapy*; D005221:Fatigue / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008074:Lipoproteins; D008193:Lyme Disease / Q000150:complications* / Q000188:drug therapy*; D020852:Lyme Neuroborreliosis / Q000188:drug therapy*; D008297:Male
D000900:Anti-Bacterial Agents; D008074:Lipoproteins; D002443:Ceftriaxone